logo

For the Inventor, By the Inventor

Ageo, Japan

Muneyoshi Ikezaki

USPTO Granted Patents = 9

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 66(Granted Patents)


Location History:

  • Ageo, JA (1976 - 1978)
  • Takarazuka, JP (1982)
  • Ageo, JP (1978 - 1984)

Company Filing History:

goldMedal9 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1976-1984

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4490392 - Benzylalcohol derivative and process for preparing (1984-12-25),
2. 4324800 - Novel benzylalcohol derivatives and processes for preparing same (1982-04-13),
3. 4276304 - Novel benzylalcohol derivative and process for preparing the same (1981-06-30),
4. 4218479 - Novel benzylalcohols and pharmaceutical compositions and use thereof (1980-08-19),
5. 4131686 - Novel benzylalcohol derivatives and processes for preparing the same (1978-12-26),
6. 4072759 - Novel benzylalcohol derivatives as antidiabetics and cardiotonics (1978-02-07),
7. 4054659 - 5,7 Dihydroxy-1-(trimethoxybenzyl)-1,2,3,H-tetrahydroisoquinolines and (1977-10-18),
8. 4032575 - Benzylalcohol amine derivatives (1977-06-28),
9. 3952021 - .alpha.-(3,4-Dimethoxyphenethylaminomethyl)-3,4 or (1976-04-20),

Title: The Innovations of Muneyoshi Ikezaki

Introduction

Muneyoshi Ikezaki is a prominent inventor based in Ageo, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on the development of novel compounds that have therapeutic applications.

Latest Patents

Ikezaki's latest patents include a benzylalcohol derivative and a process for preparing it. This compound is characterized by a specific formula where R can be hydroxy, benzyloxy, halogen, or alkoxy with one to four carbon atoms. The compound is useful as an anti-diabetic agent. Another patent involves novel benzylalcohol derivatives, which are beneficial as cardiotonic agents. These compounds are prepared through innovative processes that enhance their pharmaceutical efficacy.

Career Highlights

Muneyoshi Ikezaki is associated with Tanabe Seiyaku Company, Limited, where he has been instrumental in advancing research and development in medicinal chemistry. His expertise in synthesizing complex organic compounds has led to breakthroughs in drug formulation.

Collaborations

Ikezaki has collaborated with notable colleagues such as Taku Nagao and Nobuo Ito. Their combined efforts have contributed to the successful development of various pharmaceutical innovations.

Conclusion

Muneyoshi Ikezaki's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents not only showcase his creativity but also highlight the importance of collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…